Strategy is challenging MSCI’s proposed “nonoperating company” screen by pointing to language MSCI used in a 2022 letter to the U.S. Securities and Exchange Commission. The company argues the new methodology would force MSCI to judge whether Bitcoin should be treated as an operating asset, which it says clashes with MSCI’s stated neutrality. Strategy also says the rule would disproportionately affect MSTR, citing MSCI figures that put Strategy’s float-adjusted market capitalization at over $23.9 billion, or 86.9% of the value across six initially impacted companies.

Yum! Brands has completed the sale of Pizza Hut to private equity firm LongRange Capital, with terms not disclosed. Pizza Hut generates roughly $10 billion in global systemwide sales annually. Eduardo Luz was appointed interim CEO as the chain transitions under new ownership. Yum! Brands shares fell 0.68% on the day the completion was announced.

Injective said it completed an accelerated network upgrade on August 31, though the rollout took longer than expected. The move followed an exploit that affected a limited number of ecosystem applications running binary options markets, while the Injective blockchain and INJ remained secure. On the same date, an Injective Institutional Services affiliate said it had been registered with the U.S. Securities and Exchange Commission as a transfer agent on August 19. The upgrade was aimed at strengthening network security and stability.

Yum! Brands has closed the sale of Pizza Hut to private equity firm LongRange Capital, excluding the brand’s Mainland China operations. Pizza Hut generates about $10 billion in global systemwide sales, and LongRange has appointed Eduardo Luz as interim CEO. Yum! Brands shares fell 0.68% at the time of the announcement on September 1, 2026.

Alumis said its Phase 2b LUMUS study of envudeucitinib in moderateto-severe systemic lupus erythematosus failed to meet both primary and secondary endpoints in the overall patient population. The trial enrolled 408 patients, and the primary endpoint at Week 48 did not reach statistical significance, despite stronger responses in a prespecified IFNGShigh subgroup. Following the update, Alumis shares fell about 56%, wiping out roughly $1.5B in market value.

On its fiscal 2027 first-quarter earnings call, MiniMed reported 16% organic growth. The company said the Flex product continues to expand and has received a CE mark, while Fit has filed a 510(k) application and is expected to launch in the U.S. by summer 2027. MiniMed raised its outlook and now projects about 10.5% organic revenue growth for fiscal 2027.

The National Hurricane Center issued a hurricane watch for parts of the Texas and Louisiana coasts as Tropical Storm Edouard strengthens in the Gulf of America and moves toward a key U.S. refining and LNG corridor. Early Tuesday, the storm was about 90 miles southeast of Port Arthur, Texas. It had maximum sustained winds of 40 mph.

Pfizer shares touched a 52-week high of $29.09 on Tuesday and last traded at $28.75. The company reported Q2 2026 adjusted EPS of $0.77 on revenue of $15.03B, beating expectations of $0.68 and $14.42B. Pfizer also raised its full-year 2026 revenue outlook and said it reached a settlement covering more than 6,000 federal Depo-Provera lawsuits, removing a major legal overhang.